Live Cell Encapsulation Market: Overview

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously.

Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Live Cell Encapsulation Market: Key Trends

Increase in adoption of novel drug delivery systems for the treatment of diseases, rise in technological advancements, surge in public-private investments to support the development of novel products, expanding research activities for establishing the clinical efficacy of cell encapsulation technologies, and increase in awareness among the people about the clinical role of encapsulated cells drive the global live cell encapsulation market. However, limited availability of raw materials of high quality, inflated manufacturing costs, and rise in adoption of alternative therapies are anticipated to hamper the growth of the global market.

Live Cell Encapsulation Market: Segmentation

The global live cell encapsulation market can be segmented based on manufacturing technique, polymer type, and application. In terms of manufacturing technique, the market can be divided into coaxial airflow, simple dripping electrostatic dripping, vibrating-jet technique, liquid-jet break-up, rotating disk atomization, and jet cutting. The electrostatic dripping segment is expected to witness strong growth during the forecast period.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Based on polymer type, the global live cell encapsulation market can be classified into Hema-Mma, alginate, siliceous encapsulates, chitosan, PAN-PVC, cellulose sulfate, and others. The alginate segment is likely to grow at a rapid pace during the forecast period. In terms of application, the market can be categorized into regenerative medicine, drug delivery, probiotics, cell transplantation, and research. The drug delivery segment is projected to lead the global live cell encapsulation market during the forecast period.

Live Cell Encapsulation Market: Regional Analysis

In terms of region, the global live cell encapsulation market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to lead the global market, attributed to rise in clinical data about the efficacy of cell encapsulation technique and increase in adoption of cell encapsulation techniques by medical professionals.

Additionally, surge in research activities related to cell encapsulation and rise in public & private investments in health care drive the live cell encapsulation market in North America. The market in Asia Pacific is expected to witness strong growth during the forecast period due to increase in research and development activities, rise in government initiatives to improve health care, and surge in focus of key players in enhancing their positions in the region.

Live Cell Encapsulation Market: Competitive Landscape

Key players in the global live cell encapsulation market include BioTime, Inc., ViaCyte, Inc., Encapsys, LLC, Reed Pacific Pty Limited, Living Cell Technologies Limited, Neurotech, Sigilon Therapeutics, Inc., Merck KGaA, Lycored, and BÜCHI Labortechnik AG. These players have adopted strategies such as partnerships, agreements, new product development, and collaborations to gain competitive advantage in the global live cell encapsulation market.